Table 2.
Subgroup analysis based on different definitions of Tregs in PB of patients with SLE.
| Definition of Tregs | Number of studies | Test of association | Test of heterogeneity | Egger's test | ||||
|---|---|---|---|---|---|---|---|---|
| SMDa | 95% CI | p value | I 2 | p value | t | p | ||
| Single CD25-positive | 18 | −1.428 | (−1.982, −0.873) | <0.001 | 93.4 | <0.001 | −4.29 | 0.001 |
| CD25+ | 9 | −1.512 | (−2.488, −0.535) | 0.002 | 93.9 | <0.001 | −4.20 | 0.004 |
| CD25bright | 2 | −3.495 | (−9.197, 2.207) | 0.230 | 97.9 | <0.001 | — | — |
| CD25high | 7 | −1.074 | (−1.830, −0.318) | 0.005 | 92.0 | <0.001 | −4.28 | 0.008 |
| Associated with FOXP3-positive | 29 | −0.043 | (−0.641, 0.554) | 0.887 | 96.3 | <0.001 | 0.55 | 0.585 |
| CD25low/−FOXP3+ | 4 | 5.275 | (1.415, 9.136) | 0.007 | 98.3 | <0.001 | 4.05 | 0.056 |
| FOXP3+ | 2 | 1.377 | (0.124, 2.631) | 0.031 | 80.1 | 0.025 | — | — |
| CD25+FOXP3+ | 13 | −1.142 | (−1.942, −0.341) | 0.005 | 95.2 | <0.001 | −2.01 | 0.069 |
| CD25highFOXP3+ | 10 | −0.701 | (−1.283, −0.118) | 0.018 | 89.6 | <0.001 | −0.63 | 0.544 |
| Associated with CD127-negative | 8 | −1.093 | (−2.002, −0.183) | 0.018 | 92.6 | <0.001 | −3.05 | 0.022 |
| CD25+CD127− | 4 | −1.128 | (−1.894, −0.361) | 0.004 | 81.0 | 0.001 | −1.12 | 0.379 |
| CD25bright/highCD127low/− | 2 | −12.392 | (−37.922, 12.138) | 0.341 | 97.5 | <0.001 | — | — |
| CD25highCD127low/−FOXP3+ | 2 | −0.667 | (−2.664, 1.331) | 0.513 | 96.1 | <0.001 | — | — |
PB: peripheral blood; SLE: systemic lupus erythematosus; SMD: standard mean difference; CI: confidence interval; I 2: I-squared index. aMagnitude of Cohen's d effect size (SMD): 0.2–0.5, small effect; 0.5–0.8, medium effect; ≥0.8, large effect.